|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
KCT |
|
Last refreshed on:
|
24 June 2021 |
|
Main ID: |
KCT0006217 |
|
Date of registration:
|
2021-06-02 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Measurement of indoor air pollution exposure and health impact analysis in patients with idiopathic pulmonary fibrosis
|
|
Scientific title:
|
Measurement of indoor air pollution exposure and health impact analysis in patients with idiopathic pulmonary fibrosis |
|
Date of first enrolment:
|
2021-06-28 |
|
Target sample size:
|
120 |
|
Recruitment status: |
Not yet recruiting |
|
URL:
|
https://cris.nih.go.kr/cris/search/detailSearchEn.do?seq=19719 |
|
Study type:
|
Observational Study |
|
Study design:
|
Observational Study Model : Cohort, Time Perspective : Prospective, Enrollment : 120, Biospecimen Retention : Collect & Archive- Sample with DNA, Biospecimen Description : serum, buffy coat
|
|
Phase:
|
NA
|
|
|
Countries of recruitment
|
|
Korea, Republic of
| | | | | | | |
|
Contacts
|
|
Name:
|
Hee Young
Yoon |
|
Address:
|
38, Yangwonyeok-ro, Jungnang-gu, Seoul, Republic of Korea
|
|
Telephone:
|
+82-2-2036-0404 |
|
Email:
|
bluecat-s@hanmail.net |
|
Affiliation:
|
Seoul Bukbu Hospital |
|
|
Name:
|
Jin Woo
Song |
|
Address:
|
88, Olympic-ro 43-gil, Songpa-gu, Seoul, Republic of Korea
|
|
Telephone:
|
+82-2-3010-8532 |
|
Email:
|
skysong3@hanmail.net |
|
Affiliation:
|
Asan Medical Center |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: -Meet the international diagnostic guidelines for IPF in the ATS/ERS/JRS/ALAT revised in 2018
-Residing in Seoul and the metropolitan area
-Forced vital capacity 40%-80% pred and diffusing capacity for carbon monoxide 30-80% pred are satisfied in the lung function test.
Exclusion criteria: -Under 50
-Smoker
Age minimum:
51?(Year)
Age maximum:
No Limit
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
|
|
Diseases of the respiratory system
|
|
Primary Outcome(s)
|
|
disease progression including death, hospitalization, and decline in forced vital capacity
|
|
Secondary Outcome(s)
|
|
changes in lung function measured by home spirometry, changed in biomarker
|
|
Source(s) of Monetary Support
|
|
Korea Disease Control and Prevention Agency
|
|
Ethics review
|
Status: Submitted approval
Approval date: 25/05/2021
Contact:
+82-2-3010-7166
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|